BAWEI
837023
XI'AN WONDER
836419
Jiangsu Tiangong Technology
920068
4
Fujian Green Pine
300132
5
Yili Chuanning Biotechnology
301301
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | ||||||||||
Goods sale service render cash | 2.40%3.79B | 0.45%16.11B | -3.63%10.49B | 1.62%7.33B | -4.84%3.7B | -9.55%16.04B | -15.81%10.89B | -20.41%7.21B | -12.66%3.89B | -1.01%17.74B |
Refunds of taxes and levies | ---- | 1,432.95%89.92M | 12,977.77%64.26M | --0 | ---- | -32.74%5.87M | -94.37%491.39K | -73.87%83.65K | ---- | 1,209.18%8.72M |
Net deposit increase | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
Net increase in borrowings from central bank | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
Net increase in placements from other financial institutions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
Cash received from interests, fees and commissions | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
Net increase in repurchase business capital | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
Premiums received from original insurance contracts | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
Net cash received from reinsurance business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
Net increase in deposits from policyholders | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
Net increase in funds disbursed | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
Net cash received from trading securities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
Cash received relating to other operating activities | 33.07%112.67M | -15.17%429.4M | -2.72%317.85M | 0.29%193.28M | -17.41%84.67M | 26.30%506.21M | 35.92%326.74M | 51.09%192.73M | 71.04%102.52M | 103.49%400.8M |
Cash inflows from operating activities | 3.08%3.91B | 0.48%16.63B | -3.04%10.87B | 1.58%7.52B | -5.17%3.79B | -8.77%16.55B | -14.92%11.21B | -19.42%7.41B | -11.56%4B | 0.17%18.15B |
Goods services cash paid | -14.84%2.78B | -1.56%15.08B | -0.93%9.22B | -0.72%6.5B | -5.60%3.26B | -0.60%15.32B | -16.47%9.31B | -15.30%6.55B | -11.00%3.45B | 16.54%15.41B |
Staff behalf paid | -0.05%219.75M | 0.73%711.59M | -4.15%490.66M | -0.07%367.65M | 4.04%219.87M | 1.58%706.43M | 11.82%511.9M | 6.97%367.91M | 5.03%211.34M | 6.88%695.45M |
All taxes paid | -49.93%32.08M | -28.69%200.26M | -18.63%166.15M | -10.11%122.9M | 8.92%64.06M | -55.18%280.82M | -61.16%204.19M | -68.45%136.72M | -81.11%58.82M | -24.83%626.61M |
Net loan and advance increase | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
Net deposit in central bank and institutions | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
Net lend capital | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
Cash paid for fees and commissions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
Cash paid for indemnity of original insurance contract | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
Policy dividend cash paid | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
Cash paid relating to other operating activities | -62.35%103.84M | -41.14%226.94M | 5.74%451.03M | 14.12%302.9M | 60.57%275.84M | -4.64%385.58M | 13.00%426.55M | 3.17%265.42M | 149.38%171.78M | 21.01%404.32M |
Cash outflows from operating activities | -18.00%3.13B | -2.83%16.22B | -1.16%10.33B | -0.33%7.29B | -1.95%3.82B | -2.61%16.69B | -16.43%10.45B | -16.51%7.32B | -12.70%3.9B | 13.93%17.14B |
Net cash flows from operating activities | 2,490.10%772.45M | 395.92%411.93M | -28.72%543.17M | 159.06%229.91M | -132.90%-32.32M | -113.84%-139.2M | 13.16%762.04M | -79.18%88.75M | 82.95%98.24M | -67.23%1.01B |
Investing cash flow | ||||||||||
Cash received from disposal of investments | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
Cash received from returns on investments | -65.51%16.84M | 14.98%268.05M | 20.67%207.83M | 63.53%124.62M | 230.24%48.83M | 39.10%233.13M | 20.87%172.23M | -6.23%76.2M | -58.19%14.79M | -14.85%167.6M |
Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | --171.54K | 2,464.77%56.99M | 181.30%2.3M | 16.10%950.28K | ---- | -69.53%2.22M | 88.47%818.47K | 2,380.20%818.47K | ---- | 58.28%7.29M |
Net cash received from disposal of subsidiaries and other business units | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
Cash received relating to other investing activities | -33.36%1.4B | 30.73%8.54B | 48.26%5.89B | 90.16%4.53B | 104.81%2.1B | -7.07%6.53B | -30.45%3.97B | -35.72%2.38B | -44.88%1.03B | -27.92%7.03B |
Cash inflows from investing activities | -34.08%1.42B | 30.99%8.87B | 47.14%6.1B | 89.31%4.66B | 106.59%2.15B | -6.06%6.77B | -29.19%4.15B | -35.07%2.46B | -45.13%1.04B | -27.62%7.21B |
Cash paid to acquire fixed assets intangible assets and other long-term assets | -64.87%28.61M | -36.67%461.64M | -22.67%200.85M | -18.66%157.57M | 124.19%81.45M | -7.28%728.98M | -60.96%259.72M | -66.77%193.73M | -85.99%36.33M | -15.44%786.25M |
Cash paid to acquire investments | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
Net cash paid to acquire subsidiaries and other business units | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
Impawned loan net increase | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
Cash paid relating to other investing activities | 233.29%2.19B | -17.32%6.63B | -2.30%4.83B | 8.01%3.31B | -45.80%657.08M | 17.39%8.01B | -9.58%4.94B | -6.62%3.07B | -7.57%1.21B | -39.87%6.83B |
Cash outflows from investing activities | 200.41%2.22B | -18.93%7.09B | -3.31%5.03B | 6.42%3.47B | -40.85%738.53M | 14.84%8.74B | -15.15%5.2B | -15.69%3.26B | -20.51%1.25B | -38.02%7.61B |
Net cash flows from investing activities | -156.94%-802.6M | 190.16%1.78B | 201.78%1.07B | 248.49%1.19B | 775.06%1.41B | -384.68%-1.97B | -285.86%-1.05B | -930.82%-800.16M | -164.41%-208.81M | 82.51%-407.15M |
Financing cash flow | ||||||||||
Cash received from capital contributions | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
-Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
Cash from borrowing | 305.25%8.19B | 69.03%18.33B | 212.70%12.15B | 302.86%6.24B | 708.46%2.02B | 268.55%10.84B | 242.27%3.89B | 143.93%1.55B | 18.92%250M | 86.81%2.94B |
Cash received relating to other financing activities | ---- | ---- | ---- | --2.57B | --1.22B | ---- | ---- | --0 | ---- | ---- |
Cash inflows from financing activities | 152.98%8.19B | 69.03%18.33B | 212.70%12.15B | 468.72%8.81B | 1,195.07%3.24B | 268.55%10.84B | 78.04%3.89B | 14.20%1.55B | 18.92%250M | 86.81%2.94B |
Borrowing repayment | 72.82%5.9B | 378.45%17.56B | 422.14%9.01B | 759.48%8.46B | 578.49%3.41B | 131.76%3.67B | 130.06%1.73B | 145.83%983.86M | 286.92%503M | -5.03%1.58B |
Dividend interest payment | -50.77%6.21M | -14.31%202.97M | 2.41%144.39M | 5.86%135.08M | -3.55%12.61M | -64.40%236.87M | -56.41%140.99M | -59.65%127.6M | 91.12%13.07M | 12.46%665.4M |
-Including:Cash payments for dividends or profit to minority shareholders | ---- | -91.97%7.51M | -34.00%3.96M | --3.96M | ---- | -79.69%93.52M | -95.26%6M | --0 | ---- | 37.93%460.41M |
Cash payments relating to other financing activities | --2.67B | -73.63%1.47B | 98.85%3.48B | --354.41M | ---- | 2,694.49%5.59B | 78.94%1.75B | --0 | ---- | 1,493.08%200M |
Cash outflows from financing activities | 150.36%8.58B | 102.55%19.23B | 249.36%12.64B | 704.84%8.95B | 563.74%3.43B | 287.77%9.5B | 76.30%3.62B | -20.29%1.11B | 277.13%516.07M | 7.81%2.45B |
Net cash flows from financing activities | -105.25%-385.34M | -166.93%-902.78M | -281.16%-486.49M | -130.39%-133.1M | 29.44%-187.75M | 173.21%1.35B | 105.47%268.55M | 1,265.05%438.05M | -462.60%-266.07M | 170.91%493.7M |
Net cash flow | ||||||||||
Exchange rate change effecting cash and cash equivalents | -45.51%-240.01K | 396.32%6.36M | 71.46%-1.73M | 95.65%-244.69K | 96.73%-164.94K | -259.32%-2.15M | -233.25%-6.06M | -346.22%-5.63M | -24,729.99%-5.04M | -18.71%1.35M |
Net increase in cash and cash equivalents | -134.95%-415.73M | 269.06%1.29B | 3,896.99%1.13B | 560.48%1.28B | 411.60%1.19B | -170.00%-765.85M | -105.61%-29.71M | -190.06%-278.99M | -184.59%-381.69M | 2,143.45%1.09B |
Add:Begin period cash and cash equivalents | 233.90%1.85B | -58.05%553.54M | -58.05%553.54M | -58.05%553.54M | -56.06%553.54M | 696.72%1.32B | 696.72%1.32B | 696.72%1.32B | 660.63%1.26B | 41.74%165.6M |
End period cash equivalent | -17.81%1.43B | 233.90%1.85B | 30.38%1.68B | 76.69%1.84B | 98.53%1.74B | -56.06%553.54M | 85.65%1.29B | 118.86%1.04B | 42.33%877.93M | 660.63%1.26B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
Auditor | -- | Tianheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianheng Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.